Interesting and thanks for sharing, but I had understood that the tests had only demonstrated an apparent advantage in stopping mild symptoms over the control—and that neither study group out of the 22000 in total had actually contracted serious symptoms during the trial. That of course is not surprising given that they avoided testing any elderly or otherwise high risk groups (or those with a known allergy to anything).
” but I had understood that the tests had only demonstrated an apparent advantage in stopping mild symptoms over the control—”
Cases: Placebo - 162. Vaccine - 8
Severe: Placebo - 9. Vaccine - 1